Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas | Zendy

Renata S. Auriemma | Zendy; Mariano Galdiero | Zendy; Pasquale Vitale | Zendy; Luciana Granieri | Zendy; Fabio Lo Calzo | Zendy; Ciro Salzano | Zendy; Lucia Ferreri | Zendy; Claudia Pivonello | Zendy; Federica Cariati | Zendy; Giorgio Coppola | Zendy; Cristina de Angelis | Zendy; Annamaria Colao | Zendy; Rosario Pivonello | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas

Author(s) -

Renata S. Auriemma,

Mariano Galdiero,

Pasquale Vitale,

Luciana Granieri,

Fabio Lo Calzo,

Ciro Salzano,

Lucia Ferreri,

Claudia Pivonello,

Federica Cariati,

Giorgio Coppola,

Cristina de Angelis,

Annamaria Colao,

Rosario Pivonello

Publication year - 2015

Publication title -

neuroendocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.493

H-Index - 101

eISSN - 1423-0194

pISSN - 0028-3835

DOI - 10.1159/000371851

Subject(s) - medicine , endocrinology , insulin resistance , homeostatic model assessment , body mass index , waist , cabergoline , lipid profile , testosterone (patch) , insulin , prolactin , cholesterol , hormone

Hyperprolactinemia and hypogonadism are reportedly associated with an impaired metabolic profile. The current study aimed at investigating the effects of testosterone replacement and cabergoline (CAB) treatment on the metabolic profile in male hyperprolactinemic patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research